Compare SPPL & ALUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | SPPL | ALUR |
|---|---|---|
| Founded | 2016 | 2009 |
| Country | Singapore | United States |
| Employees | N/A | N/A |
| Industry | | |
| Sector | | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 19.5M | 18.9M |
| IPO Year | 2023 | N/A |
| Metric | SPPL | ALUR |
|---|---|---|
| Price | $4.60 | $1.44 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $9.25 |
| AVG Volume (30 Days) | 4.1K | ★ 113.3K |
| Earning Date | 04-10-2026 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $4,591,508.00 | ★ $17,208,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $9.02 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 24.27 | N/A |
| 52 Week Low | $2.18 | $1.02 |
| 52 Week High | $16.80 | $16.81 |
| Indicator | SPPL | ALUR |
|---|---|---|
| Relative Strength Index (RSI) | 47.62 | 41.88 |
| Support Level | $4.30 | $1.31 |
| Resistance Level | $5.36 | $1.71 |
| Average True Range (ATR) | 0.36 | 0.12 |
| MACD | 0.04 | -0.00 |
| Stochastic Oscillator | 46.48 | 29.45 |
Simpple Ltd delivers an ecosystem solution that combines Internet-of-Things devices, robotic solutions, and an integrated software system operating in unison to position buildings to be future-ready. The company operates through two primary segments: the sale, warranty, and maintenance of autonomous robotic cleaning equipment (Robots), and the sale of facilities management software. The majority of its revenue is generated from the Robots segment.
Allurion Technologies Inc is a medical device company that focuses on creating a weight loss platform to treat overweight patients. Its platform, the Allurion Program, features the world's first and only swallowable, procedure-less intragastric balloon for weight loss and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion VCS. Its proprietary intragastric balloon, the Allurion Balloon, is in the form of a swallowed capsule that is administered to patients under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia.